Evaluation of the therapeutic effect of <em>Nigella sativa</em> crude oil and its blend with omega-3 fatty acid-rich oils in a modified hepatorenal syndrome model in rats

S. Y. Al-Okbi; D. A. Mohamed; T. E. Hamed; A. E. Edris

doi:10.3989/gya.0245151

Authors

S. Y. Al-Okbi Department of Food Sciences and Nutrition, National Research Centre
D. A. Mohamed Department of Food Sciences and Nutrition, National Research Centre
T. E. Hamed Department of Food Sciences and Nutrition, National Research Centre
A. E. Edris Aroma and Flavor Chemistry Department, National Research Centre

DOI:

https://doi.org/10.3989/gya.0245151

Keywords:

Hepatorenal syndrome, Nigella crude oil, Oil blends, Omega-3 fatty acids

Abstract

In the present study, the hepato and reno-protective effect of Nigella sativa crude oil and its binary blend with omega-3 fatty acid-rich oils (fish and flaxseed oils) was studied in a modified hepatorenal syndrome model (MHRS) in rats. MHRS was induced through feeding a high fructose diet followed by an intraperitoneal injection of galactosamine hydrochloride. Nigella oil and its different blends were given as a daily oral dose to MHRS rats. Two control groups of MHRS and normal healthy rats were run. Different biochemical and nutritional parameters were assessed. The induction of MHRS produced liver and kidney dysfunction, and elevated oxidative stress, an inflammatory biomarker, endothelin 1, and plasma cholesterol. Reduced plasma high density lipoprotein cholesterol, albumin and Ca and elevated urinary N-acetyl-β-D-Glucosaminidase and liver fats were noticed. The administration of Nigella crude oil that originally had 0.2% total omega-3 fatty acids or its blend with fish oil (17.9% omega-3) or flaxseed oil (42.1% omega-3) significantly improved all biochemical parameters of MHRS. There was no significant difference in the biochemical parameters among the different oil treated groups regardless of the omega-3 fatty acid content. This may point out to the potential profound effect of the volatile oil fraction of Nigella crude oil which may compensates for its low omega-3 content.

Downloads

Download data is not yet available.

References

Abdel-Moneima E, Dkhila A, Al-Quraishy S. 2011. The protective effect of flaxseed oil on lead acetate-induced renal toxicity in rats. J. Hazard. Mater. 194, 250–255. http://dx.doi.org/10.1016/j.jhazmat.2011.07.097 PMid:21872391

Al-Bishri M. 2013. Favorable effects of flaxseed supplemented diet on liver and kidney functions in hypertensive Wistar rats. J. Oleo Sci. 62, 709–715. http://dx.doi.org/10.5650/jos.62.709 PMid:24005015

Al-Okbi S, Ammar N, Abd El-Kader M. 1997. Studies of some biochemical, nutritional and anti-inflammatory effects of Nigella Sativa seeds. Egypt. J. Pharmaceut. Sci. 38, 451–469.

Al-Okbi S, Mohamed D. 2012. Preparation and Evaluation of functional foods in adjuvant arthritis. Grasas Aceites. 63, 394-402. http://dx.doi.org/10.3989/gya.130811

Al-Okbi S, Mohamed D, Hamed Th, Edris A. 2013. Potential protective effect of Nigella sativa crude oils towards fatty liver in rats. Eur. J. Lipid Sci. Technol. 115, 774–782. http://dx.doi.org/10.1002/ejlt.201200256

Al-Okbi S, Mohamed D, Hamed Th, Esmail S, Donya M. 2014. Prevention of renal dysfunction by nutraceuticals prepared from oil rich plant foods. Asian Pacific J. Trop. Biomed. 4, 618–627. http://dx.doi.org/10.12980/APJTB.4.201414B66 PMid:25183331 PMCid:PMC4037655

Al-Suhaimi A. 2012. Hepatoprotective and immunological functions of Nigella sativa seed oil against hypervitaminosis A in adult male rats. Inter. J. Vitamin and Nutr. Res. 82, 288–297. http://dx.doi.org/10.1024/0300-9831/a000121 PMid:23591666

Anand R, Harry D, Holt S, Milner P, Dashwood M, Goodier D, Jarmulowicz M, Moore K. 2002. Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure. Gut. 50, 111–117. http://dx.doi.org/10.1136/gut.50.1.111 PMid:11772977 PMCid:PMC1773076

Ansari I, Sheikh A, Ahmed S, Jabbar Q, Ali S. 2014. Management of anemia and other hematologic derangements in patients with chronic kidney disease. Arab J. Nephrol. Transplant. 7, 13–19. PMid:24702529

Arroyo V, Ginès P, Gerbes A, Dudley J, Gentilini P, Laffi G, Reynolds B, Ring-Larsen H, Schölmerich J. 1996. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatol. 23, 164–176. http://dx.doi.org/10.1002/hep.510230122 PMid:8550036

Aydogdu S, Akil I, Akil T, Akil T, Kabasakal C, Killi R, Mir S, Yag˘ci R. 2004. Renal resistive indexes and some renal functions in liver cirrhotic children. Pediatr. Int. 46, 67–71. http://dx.doi.org/10.1111/j.1442-200X.2004.01826.x PMid:15043668

Azar R, Dequiedt F, Awada J, Dequiedt P, Tacquet A. 1989. Effects of fish oil rich in polyunsaturated fatty acids on hyperlipidemia of hemodialysis patients. Kidney Int. 27, S239-S242.

Baggio B, Budakovic A, Priante G, Gambaro G, Manzato E, Khan S. 2002. Dietary fatty acid supplementation modulates the urinary excretion of calcium and oxalate in the rat. Insight into calcium lithogenesis. Nephron. 91, 486–491. http://dx.doi.org/10.1159/000064292 PMid:12119482

Bataller R, Sort P, Gine's P, Arroyo V. 1998. Hepatorenal syndrome: definition, pathophysiology, clinical features and management. Kidney Int. Suppl. 66, S47–S53. PMid:9573573

Bibus M, Stitt P, Holman T. 1998. Ratios of linoleic to a-linolenic acids in the diet: Implications in the health of humans and companion animals, in Proceedings of the 57th Flax Institute of the U.S., Fargo, ND, pp. 49–52.

Briggs M, Williams A. 1963. A new mineral mixture for experimental rat diets and evaluation of other mineral mixtures. Feder. Proceedings. 22, 261–266.

Burstein M, Scholnick H, Morfin R. 1970. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J. Lipid Res. 11, 583–595. PMid:4100998

Caligiuri P, Love K, Winter T, Gauthier J, Taylor G, Blydt-Hansen T, Zahradka P, Aukema M. 2013. Dietary linoleic acid and α-linolenic acid differentially affect renal oxylipins and phospholipid fatty acids in diet-induced obese rats. J. Nutrit. 143, 1421–1431. http://dx.doi.org/10.3945/jn.113.177360 PMid:23902961

Cequier-Sánchez E, Rodríguez C, Ravelo G, Zárate R. 2008. Dichloromethane as a solvent for lipid extraction and assessment of lipid classes and fatty acids from samples of different natures. J. Agric. Food Chem. 56, 4297–4303. http://dx.doi.org/10.1021/jf073471e PMid:18505264

Cheikh-Rouhou S, Besbes S, Lognay G, Blecker C, Deroanne C, Attia H. 2008. Sterol composition of black cumin (Nigellas ativa L.) and Aleppo pine (Pinus halepensis Mill.) seed oils. J. Food Comp. Anal. 21, 162–168. http://dx.doi.org/10.1016/j.jfca.2007.09.001

Clark F, Parbtani A, Huff W, Spanner E, de Salis H, Chin-Yee I, Philbrick J, Holub J. 1995. Flaxseed: a potential treatment for lupus nephritis. Kidney Int. 48, 475–483. http://dx.doi.org/10.1038/ki.1995.316 PMid:7564115

Davenport A, Ahmad J, Khafaji A, Kellum J, Genyk S, Nadim K. 2012. Medical management of hepatorenal syndrome. Nephrol. Dial Transpl. 27, 34–41. http://dx.doi.org/10.1093/ndt/gfr736 PMid:22287700

De Caterina R, Endres S, Kristesen S, Schmidt E. 1994. n-3 Fatty acids and renal diseases. Amer. J. Kidney Dis. 24, 397–415. http://dx.doi.org/10.1016/S0272-6386(12)80896-1

Demirbas T, Piskin T, Dayangac M, Yaprak O, Oklu L, Yuzer Y, Tokat Y. 2012. Successful treatment of severe hepatorenal syndrome with living donor liver transplantation. Hepatogastroenterol. 59, 2305–2306.

Donadio V. 2001. n-3 Fatty acids and their role in nephrologic practice. Current Opin. Nephrol. Hyperten. 10, 639–642. http://dx.doi.org/10.1097/00041552-200109000-00014 PMid:11496058

Doumas T, Watson A, Biggs G. 1972. Albumin standards and the measurement of serum albumin with bromocresol green. Clin. Chem. Acta. 31, 87–96. http://dx.doi.org/10.1016/0009-8981(71)90365-2

European Pharmacopoeia 1996. Conseil de l'Europe: Pharmacopée Européenne. France: Maisonneuve S.A., Sainte Ruffine.

Fagundes C, Ginè P. 2012. Hepatorenal syndrome: A severe, but treatable, cause of kidney failure in cirrhosis. Am. J. Kidney Dis. 59, 874–885. http://dx.doi.org/10.1053/j.ajkd.2011.12.032 PMid:22480795

Fawcett K, Scott E. 1960. A rapid and precise method for the determination of urea. J. Clin. Pathol. 13, 156–159. http://dx.doi.org/10.1136/jcp.13.2.156 PMid:13821779 PMCid:PMC480024

Fernandez R, Piechnik J, Fabris R, Malnic G, Fernandes L. 2004. Effect of chronic fish oil supplementation on renal function of normal and cachectic rats. Brazil. J. Med. Biolog. Res. 37, 1481–1489. http://dx.doi.org/10.1590/S0100-879X2004001000006

Folch J, Lees M, Sloane-Stanley H. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497–509. PMid:13428781

Gambino R. 1965. Standard Methods of Clinical Chemistry. Academic Press, New York.

Garcia-Martinez R, Caraceni P, Bernardi M, Gines P, Arroyo V, Jalan R. 2013. Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatol. 58, 1836–1846. http://dx.doi.org/10.1002/hep.26338 PMid:23423799

Harats D, Dabach Y, Hollander G, Ben-Naim M, Schwartz R, Berry EM, Stein O, Stein Y. 1991. Fish oil ingestion in smokers and nonsmokers enhances peroxidation of plasma lipoproteins. Atheroscler. 90, 127–139. http://dx.doi.org/10.1016/0021-9150(91)90107-E

Higdon V, Liu J, Du H, Morrow D, Ames N, Wander C. 2000. Supplementation of postmenopausal women with fish oil rich in eicosapentaenoic acid and docosahexaenoic acid is not associated with greater in vivo lipid peroxidation compared with oils rich in oleate and linoleate as assessed by plasma malondialdehyde and F2-isoprostanes1–3. Am. J. Clin. Nutr. 72, 714–722. PMid:10966889

Houcher Z, Boudiaf K, Benboubetra M, Houcher B. 2007. Effects of methanolic extract and commercial oil of Nigella sativa L. on blood glucose and antioxidant capacity in alloxan-induced diabetic Rats. Pteridines. 18, 8–18. http://dx.doi.org/10.1515/pteridines.2007.18.1.8

Houot O. 1985. Interpretation of Clinical Laboratory Tests. Biomedical Publications. (Doi not available).

Jenkins G, Kendall W, Vidgen E, Agarwal S, Rao V, Rosenberg S, Diamandis P, Novokmet R, Mehling C, Perera T, Griffin C, Cunnane C. 1999. Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measure and ex vivo androgen and progestin activity: a controlled cross-ovar trial. Am. J. Clin. Nutr. 69, 395–403. PMid:10075322

Kamisako T, Miyawaki S, Gabazza C, Ishihara T, Kamei A, Kawamura N, Adachi Y. 1998. Polyethylene glycol-modified bilirubin oxidase improves hepatic energy charge and urinary prostaglandin levels in rats with obstructive jaundice. J. Hepatol. 29, 424–429. http://dx.doi.org/10.1016/S0168-8278(98)80060-3

Kawasaki T, Igarashi K, Koeda T, Sugimoto K, Nakagawa K, Hayashi S, Yamaji R, Inui H, Fukusato T, Yamanouchi T. 2009. Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic Steatosis. J. Nutr. 139, 2067–2071. http://dx.doi.org/10.3945/jn.109.105858 PMid:19776184

Koracevic D, Koracevic G, Djordjevic V, Anderejevic S, Cosic V. 2001. Methods for the measurement of antioxidant activity in human fluids. J. Clin. Pathol. 54, 356–361. http://dx.doi.org/10.1136/jcp.54.5.356 PMid:11328833 PMCid:PMC1731414

Mattson H, Grundy M. 1985. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J. Lipid Res. 26, 194–202. PMid:3989378

Megraw R, Dunn D, Biggs H. 1979. Manual and continuous flow colorimetry of triglycerols by a fully enzymatic method. Clin. Chem. 25, 273–284. PMid:759021

Mensink P, Katan B. 1992. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler. Thrombo. Vascular Biol. 12, 911–919. http://dx.doi.org/10.1161/01.ATV.12.8.911

Meydani M, Natiello F, Goldin B, Free N, Woods M, Schaefer E, Blumberg B, Gorbach L. 1991. Effect of long-term fish oil supplementation on vitamin E status and lipid peroxidation in women. J. Nutr. 121, 484–91. PMid:1826131

Mohamed A, El-Hariri M, Al-Okbi Y. 2005. Impact of feeding bread enriched with flaxseed on plasma profile of hyperlipidemic rats. Polish J. Food Nutr. Sci. 14 (4), 431–436.

Mohindra S, Kumar K. 2013. Hepatorenal syndrome clinical queries. Nephrol. 2, 205–211.

Morcos R. 1967. The effect of protein value of the diet on the neurological manifestations produced in rats by b–immodipropionitrile. British J. Nutr. 21, 269–274. http://dx.doi.org/10.1079/BJN19670029 PMid:4952258

Mu-oz S. 2008. The hepatorenal syndrome. Medical Clin. 92 (4), 813–837.

Oomah D, Mazza G. 1995. Flaxseed dietary fiber and cyanogens, in Cunnane, S., Thompson, L (Ed.) Flaxseed in Human Nnutrition. Champaign, AOCS Press Illinois, USA, pp. 56–67.

Planas R, Montoliu S, Balleste B, Rivera M. Miquel M, Masnou H, Galeras A, Giménez D, Santos J, Cirera I, Morillas M, Coll S, Solà R. 2006. Natural history of patients hospitalized for management of cirrhotic ascites. Clin. Gastroenterol. Hepatol. 4, 1385–1394. http://dx.doi.org/10.1016/j.cgh.2006.08.007 PMid:17081806

Price G, Whiting H. 1992. Urinary enzymes and nephrotoxicity in humans, in Jung K, Mattenheimer H, Burchardt U (Ed.) Urinary Enzymes Springer-Verlag, Berlin, pp. 203–221. http://dx.doi.org/10.1007/978-3-642-84313-6_14 PMid:1563256

Pszczola E. 1998. The ABCs of nutritional ingredients. Food Technol. 52, 30–38.

Ramadan F, Wahdan K. 2012. Blending of corn oil with black cumin (Nigella sativa) and coriander (Coriandrum sativum) seed oils: Impact on functionality, stability and radical scavenging activity. Food Chem. 132, 873–879. http://dx.doi.org/10.1016/j.foodchem.2011.11.054

Raptis D, Limani P, Jang J, Ungethu.m U, Tschuor C, Graf R, Humar B, Clavien A. 2014. GPR120 on Kupffer cells mediates hepatoprotective effects of ω3-fatty acids. J. Hepatol. 60, 625–632. http://dx.doi.org/10.1016/j.jhep.2013.11.006 PMid:24262133

Reitman S, Frankel S. 1957. Colorimetric methods for aspartate and alanine aminotransferase. Am. J. Clin. Pathol. 28, 55–60.

Saracyn M, Patera J, Kocik J, Brytan M, Zdanowski R, Lubas A, Kozłowski W, Wan’kowicz Z. 2012. Strain of experimental animals and modulation of nitric oxide pathway: their influence on development of renal failure in an experimental model of hepatorenal syndrome. Arch. Medical Sci. 8, 555–562. http://dx.doi.org/10.5114/aoms.2012.29281 PMid:22852015 PMCid:PMC3400905

Saracyn M, Wesołowski P, Nowak Z, Patera J, Kozłowski W, Wan’kowicz Z. 2008. Race of experimental animals and development of renal failure in animal model of hepatorenal syndrome. Polish Merkur Lekarski. 24, 298–302.

Satoh K. 1978. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clinica Chimica Acta. 20, 37–43.

Schriewer H, Kohnert U, Assmann G. 1984. Determination of LDL cholesterol and LDL apolipoprotein B following precipitation of VLDL in blood serum with phosphotungstic acid/MgCl2. J. Clin. Chem. Clin. Biochem. 22, 35–40. http://dx.doi.org/10.1515/cclm.1984.22.1.35

Shah N, Mohamed E, Jover-Cobos M, Macnaughtan J, Davies N, Moreau R, Paradis V, Moore K, Mookerjee R, Jalan R. 2013. Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis. Liver Internation. 33, 398–409. http://dx.doi.org/10.1111/liv.12047 PMid:23402610

Simopoulos P. 1999. Essential fatty acids in health and chronic disease. Am. J. Clin. Nutr. 70, 560S–568S. PMid:10479232

Skálová S. 2005. The diagnostic role of urinary N-acetyl-beta-D-glucosaminidase (NAG) activity in the detection of renal tubular impairment. Acta Medica (Hradec Kralove). 48, 75–80.

Snowdon V, Pellicoro A, Ramachandran P, Mungall W, Jansen M, Lennen R, Aucott R, Kendall T, Hughes J, Iredale J, Fallowfield J. 2013. Relaxin is a renal vasodilator in experimental models of cirrhosis and a potential novel therapy for hepatorenal syndrome in man. The Lancet. 381, S102 (special issue). http://dx.doi.org/10.1016/S0140-6736(13)60542-5

Stepaniak A, Gould E, Sun D, Swanborg H. 1995. A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats. J. Immunol. 155, 2762–2769. PMid:7544385

Üstun G, Kent L, Cekin N, Civelekoglu, H. 1990 Investigation of the technological properties of Nigella sativa (black cumin) seed oil. J. Am. Oil Chem. Soc. 67 (12), 958–960. http://dx.doi.org/10.1007/BF02541857

Van Lente F, Sult P. 1989. Assessment of renal function by serum creatinine and creatinine clearance: Glomerular filteration rate estimated by four procedures. Clin. Chem. 35 (12), 2326–2330. PMid:2591052

VanKampen J, Zijlstra G. 1965. Determination of hemoglobin and its derivatives. Advces Clin. Chem. 8, 141–187.

Wadei H, Mai M, Ahsan N, Gonwa T. 2006. Hepatorenal syndrome: pathophysiology and management. Clin. J. Am. Soc. Nephrol. 1, 1066–1079. http://dx.doi.org/10.2215/CJN.01340406 PMid:17699328

Wander C, Du H, Ketchum O, Rowe E. 1996. Tocopherol influences in vivo indices of lipid peroxidation in postmenopausal women given fish oil. J. Nutr. 126, 643–652. PMid:8598549

Watson D. 1960. A simple method for the determination of serum cholesterol. Clin. Chem. Acta. 5, 637–642. http://dx.doi.org/10.1016/0009-8981(60)90004-8

Zhou Z, Davar G, Strichartz G. 2002. Endothelin-1 (ET-1) selectively enhances the activation gating of slowly inactivating tetrodotoxin-resistant sodium currents in rat sensory neurons: A mechanism for the pain-inducing actions of ET-1. J. Neurosci. 22 (15), 6325–6330. PMid:12151509